Billionaire Ken Griffin Likes This Homebuilder

CITADEL INVESTMENT GROUPThroughout this year, even with modest economic and job growth, the housing market has appeared to be coming back and that has caused a number of stocks tied to housing and construction to rise. Meritage Homes Corporation (NYSE:MTH) is no exception: it is up 55% year to date, which has brought its market capitalization above the ten-figure mark to a total of $1.3 billion. Citadel Advisors, a large hedge fund managed by billionaire Ken Griffin, thinks that the stock has further to go: according to a recent 13G filed with the SEC, the fund had a position of 2.0 million shares in Meritage. This gave it 5.7% of the total shares outstanding. According to our database of 13F filings, Citadel had owned 1.2 million shares of the company at the end of June, easily the largest position out of the funds and other notable investors that we track. Find more stocks that Citadel owned.

Much of Meritage’s operations are in the Sunbelt, which was hit hard by the financial crisis; however, the company seems to be rebounding strongly. In the third quarter, revenue came in 54% higher than in the third quarter of 2011. As a result, Meritage Homes Corporation was profitable for that period and reported 19 cents per share in earnings (it had lost 10 cents per share a year earlier). In the first three quarters of the year, the company had EPS of 30 cents. If we annualize that year to date performance (which, obviously, comes out to 40 cents per share), then the stock is trading at a P/E of 92.

Meritage’s pricing is based on expectations of future growth: Wall Street analysts expect a very good fourth quarter, and the consensus for 2013 is $2.05 in earnings per share. That would imply a forward P/E of 24, so after that point Meritage Homes Corporation would have to continue growing. Yet if the housing market does have as much pent-up demand as some think, that could be achievable and that seems to be what Citadel is going for in an investment thesis. Jeffrey Vinik’s Vinik Asset Management had a smaller position at the end of June than Citadel- at about 180,000 shares- but all of those had been purchased in the second quarter of the year, representing another fund that was buying the stock. See more stock picks from Vinik Asset Management.

Larger U.S. homebuilders include Lennar Corporation (NYSE:LEN), D.R. Horton, Inc. (NYSE:DHI), PulteGroup, Inc. (NYSE:PHM), and Toll Brothers Inc (NYSE:TOL). Read our recent article on Lennar. These companies have market caps between $5 billion and $8 billion, so while they are not megacaps they are considerably larger than Meritage by that metric. On a forward basis, Meritage is about in the middle of this peer group: Lennar and DR Horton trade at 23-24 times forward earnings estimates, with PulteGroup’s P/E being a bit below that figure and Toll Brothers carrying a moderate premium. However, all of these companies are cheaper on a trailing earnings basis, and therefore less dependent on hitting the sell-side’s growth targets in 2013 in order to achieve these earnings estimates. In addition, in their most recent quarter each of these four companies at least came close to matching Meritage’s revenue growth rate compared to the same period in 2011; Lennar and Toll Brothers had an even stronger performance.

As a result, while the core Citadel thesis of a better housing market may be right our impression is that there are better homebuilding stocks to play that thesis. Meritage is highly dependent on future growth to justify its current valuation, and other companies in the industry should benefit about as much from a stronger market and thus also see good growth. Lennar, for example, combines a similar forward earnings multiple with better historical growth rates on the top line.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!